Back to Browse Journals » Infection and Drug Resistance » Volume 6

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

Authors Kamali A, Holodniy M

Published Date November 2013 Volume 2013:6 Pages 187—198

DOI http://dx.doi.org/10.2147/IDR.S36601

Received 27 June 2013, Accepted 7 August 2013, Published 19 November 2013

Amanda Kamali,1 Mark Holodniy1,2

1Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA; 2Office of Public Health, Department of Veterans Affairs, Washington, DC, USA

Abstract: Influenza virus is a pathogen that causes morbidity and mortality worldwide. Whereas vaccination is important for prevention of disease, given its limitations, antiviral therapy is at the forefront of treatment and also plays a role in prevention. Currently, two classes of antiviral medications, the adamantanes and the neuraminidase inhibitors, are approved for treatment. Given the resistance patterns of circulating influenza, adamantanes are not recommended. Within the US, two neuraminidase inhibitors are currently approved for both treatment and prevention, while worldwide there are four available. In this review, we will briefly discuss the epidemiology and pathology of influenza and then discuss neuraminidase inhibitors: their mechanism of action, resistance, development, and future applications.

Keywords: influenza, antiviral, neuraminidase, resistance

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

HIV infection in the elderly

Nancy Nguyen, Mark Holodniy

Clinical Interventions in Aging 2008, 3:453-472

Published Date: 2 October 2008